The sBLA for the pediatric indication is supported by data from the randomized, double-blind, placebo-controlled, phase 3 SPACE trial.

Significant increase seen in crude nitrous oxide poisoning rate from 2010 to 2018, but no increase seen from 2019 to 2023.

Up to 6% of pediatric visits are due to complaints of sore throat. Group A Streptococcus pharyngitis is most common in children between 5 and 15 years of age, with the highest annual occurrence from ...

Recent news reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and scientific research funding in jeopardy.

Findings from key secondary endpoints showed 59.6% of patients taking orforglipron 36 mg (highest dose) achieved a reduction in body weight of 10% or greater vs 8.6% of patients receiving placebo; ...

No significant benefit seen for HEPA versus sham filter for diastolic BP or among those with normal systolic BP.